MAX Automation AG (DE000A2D)

BRIEF

published on 03/13/2024 at 09:06, 8 months 8 days ago

MAX Automation SE Witnesses Robust Growth Amid Economic Uncertainty

Economic Uncertainty Buy Recommendation Financial Growth MAX Automation SE Bdtronic
PRESS RELEASE

published on 03/13/2024 at 09:01, 8 months 8 days ago

Original-Research: MAX Automation SE (von NuWays AG): BUY
MAX Automation SE released strong FY23 results with sales and EBITDA meeting expectations. The sales process of subsidiary MA micro is ongoing, contributing to growth

Sales EBITDA FY23 Results MAX Automation SE MA Micro
BRIEF

published on 03/12/2024 at 07:35, 8 months 9 days ago

MAX Automation AG Reports Successful Fiscal Year 2023 Amid Economic Challenges

Financial Year 2023 Growth Forecast Economic Challenges MAX Automation AG Technology Sectors
PRESS RELEASE

published on 03/12/2024 at 07:30, 8 months 9 days ago

MAX Automation withstanding macroeconomic and industry challenges achieves successful financial year 2023 in line with raised forecast
MAX Automation SE reports successful financial year 2023 despite challenges, achieving sales of EUR 443.1 million and EBITDA of EUR 43.2 million. Order intake and backlog affected by investment reluctance

Sales EBITDA Financial Year 2023 MAX Automation SE Macroeconomic Challenges
PRESS RELEASE

published on 11/10/2023 at 10:02, 1 year ago

Original-Research: MAX Automation SE (von NuWays AG): BUY
PRESS RELEASE

published on 11/09/2023 at 07:30, 1 year ago

MAX Automation reports continued positive development in the first three quarters of 2023 despite macroeconomic and industry-specific challenges
PRESS RELEASE

published on 09/08/2023 at 14:45, 1 year 2 months ago

MAX Automation SE assesses the sale of the MA micro group
PRESS RELEASE

published on 09/08/2023 at 14:40, 1 year 2 months ago

EQS-Adhoc: MAX Automation SE: MAX Automation SE pursues a structured sales process for MA micro group
PRESS RELEASE

published on 08/25/2023 at 14:55, 1 year 2 months ago

MAX Automation SE following successful restructuring and strategic realignment: Supervisory Board establishes Presiding Committee - CEO Dr. Christian Diekmann leaves by mutual consent
PRESS RELEASE

published on 08/25/2023 at 14:51, 1 year 2 months ago

EQS-Adhoc: MAX Automation SE: CEO Dr. Christian Diekmann leaves the Company prematurely after successful restructuring and strategic realignment

Published on 11/21/2024 at 17:35, 16 minutes ago

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 21 minutes ago

SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 1 hour 21 minutes ago

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 50 minutes ago

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 51 minutes ago

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

View all ACCESSWIRE

Published on 11/21/2024 at 16:00, 1 hour 51 minutes ago

Director/PDMR Shareholding
Published on 11/21/2024 at 15:41, 2 hours 9 minutes ago

Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 2 hours 27 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 2 hours 28 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 2 hours 29 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc

View all EQS

Published on 11/21/2024 at 06:58, 10 hours 53 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 31 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE

News